The optimal SAM surface functional group for producing a biomimetic HA coating on Ti
Source abstract
Abstract
Abstract Commercial interest is growing in biomimetic methods that employ self assembled mono‐layers (SAMs) to produce biocompatible HA coatings on Ti‐based orthopedic implants. Recently, separate studies have considered HA formation for various SAM surface functional groups. However, these have often neglected to verify crystallinity of the HA coating, which is essential for optimal bioactivity. Furthermore, differing experimental and analytical methods make performance comparisons difficult. This article investigates and evaluates HA formation for four of the most promising surface functional groups: OH, SO3H, PO4H2 and COOH. All of them successfully formed a HA coating at Ca/P ratios between 1.49 and 1.62. However, only the SO3H and COOH end groups produced a predominantly crystalline HA. Furthermore, the COOH end group yielded the thickest layer and possessed crystalline characteristics very similar to that of the human bone. The COOH end group appears to provide the optimal SAM surface interface for nucleation and growth of biomimetic crystalline HA. Intriguingly, this finding may lend support to explanations elsewhere of why human bone sialoprotein is such a potent nucleator of HA and is attributed to the protein's glutamic acid‐rich sequences. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Calcium Carbonate Crystallization and Inhibition · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (31)
Show source-provided references
1. Hydroxyapatite‐coated titanium for orthopaedic implant applications
2. 10.1002/(SICI)1097-4636(199609)32:1<111::AID-JBM13>3.0.CO;2-P10.1002/(SICI)1097-4636(199609)32:1<111::AID-JBM13>3.0.CO;2-P ↗
3. 10.1557/JMR.1998.001510.1557/JMR.1998.0015 ↗
4. 10.1016/S0142-9612(00)00415-410.1016/S0142-9612(00)00415-4 ↗
5. 10.1016/0142-9612(90)90073-Y10.1016/0142-9612(90)90073-Y ↗
6. 10.1016/S0142-9612(03)00061-910.1016/S0142-9612(03)00061-9 ↗
7. 10.1002/jbm.82028030810.1002/jbm.820280308 ↗
8. 10.1016/0142-9612(92)90192-Q10.1016/0142-9612(92)90192-Q ↗
9. 10.1016/j.biomaterials.2003.12.03810.1016/j.biomaterials.2003.12.038 ↗
10. 10.1016/j.biomaterials.2003.09.04110.1016/j.biomaterials.2003.09.041 ↗
11. 10.1002/(SICI)1097-4636(199624)33:4<225::AID-JBM3>3.0.CO;2-R10.1002/(SICI)1097-4636(199624)33:4<225::AID-JBM3>3.0.CO;2-R ↗
12. 10.1039/a801384e10.1039/a801384e ↗
13. 10.1016/S0142-9612(02)00050-910.1016/S0142-9612(02)00050-9 ↗
14. 10.1016/S0142-9612(03)00044-910.1016/S0142-9612(03)00044-9 ↗
15. 10.1002/(SICI)1097-4636(19970305)34:3<305::AID-JBM5>3.0.CO;2-O10.1002/(SICI)1097-4636(19970305)34:3<305::AID-JBM5>3.0.CO;2-O ↗
16. 10.1021/cm001227w10.1021/cm001227w ↗
17. 10.1002/jbm.82024060710.1002/jbm.820240607 ↗
18. 10.1016/S0142-9612(01)00205-810.1016/S0142-9612(01)00205-8 ↗
19. 10.1016/j.biomaterials.2003.09.04710.1016/j.biomaterials.2003.09.047 ↗
20. 10.1016/S0142-9612(03)00244-810.1016/S0142-9612(03)00244-8 ↗
21. 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L ↗
22. 10.1016/S0142-9612(02)00576-810.1016/S0142-9612(02)00576-8 ↗
23. 10.1016/0040-6031(95)02784-X10.1016/0040-6031(95)02784-X ↗
24. 10.1016/j.biomaterials.2003.11.03010.1016/j.biomaterials.2003.11.030 ↗
25. 10.6028/jres.109.04210.6028/jres.109.042 ↗
26. 10.1016/S0142-9612(01)00390-810.1016/S0142-9612(01)00390-8 ↗
27. 10.1016/S0142-9612(03)00371-510.1016/S0142-9612(03)00371-5 ↗
28. 10.1016/0142-9612(93)90131-K10.1016/0142-9612(93)90131-K ↗
29. 10.1042/bj302017510.1042/bj3020175 ↗
30. 10.1042/bj317005910.1042/bj3170059 ↗
31. 10.1074/jbc.M21191520010.1074/jbc.M211915200 ↗